Director Diana McKenzie awarded 2,133 RSUs at agilon health (AGL), total holdings 7,633 shares

Rhea-AI Filing Summary

agilon health, inc. director Diana McKenzie received an equity grant in the form of restricted stock units. She acquired 2,133 shares of Common Stock at no cash cost as a grant or award, increasing her direct beneficial ownership to a total of 7,633 shares, including restricted stock units. The RSUs vest in full on June 2, 2027, as long as she continues to serve as a director. The ownership figure reflects the company’s 1-for-25 reverse stock split of its common stock that became effective on March 30, 2026.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider MCKENZIE DIANA

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,133	$0.00	--

Holdings After Transaction: Common Stock — 7,633 shares (Direct, null)

Footnotes (1)

1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026. Includes restricted stock units.

Key Figures

RSU grant size: 2,133 shares Grant price: $0.00 per share Post-transaction holdings: 7,633 shares +2 more

5 metrics

RSU grant size 2,133 shares Restricted stock units granted June 2, 2026

Grant price $0.00 per share Equity award, no cash consideration

Post-transaction holdings 7,633 shares Beneficially owned after transaction, includes RSUs

Reverse stock split ratio 1-for-25 Common stock reverse split effective March 30, 2026

RSU vesting date June 2, 2027 Vests in full subject to continued board service

Key Terms

Restricted stock units, beneficially owned, reverse stock split, Grant, award, or other acquisition, +1 more

5 terms

Restricted stock units financial

"Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

beneficially owned financial

"The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split..."

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

reverse stock split financial

"reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026."

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Common Stock financial

"security_title: Common Stock"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCKENZIE DIANA

(Last) (First) (Middle)

C/O AGILON HEALTH, INC.

440 POLARIS PARKWAY, SUITE 550

(Street)

WESTERVILLE OHIO 43082

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
agilon health, inc. [ AGL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		A		2,133(1)	A	$0	7,633(2)(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted stock units that vest in full on June 2, 2027, subject to continued service as a director.

2. The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.

3. Includes restricted stock units.

Remarks:

	/s/ Mimi Yang, as Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Diana McKenzie report in agilon health (AGL) Form 4?

Diana McKenzie reported receiving 2,133 shares of agilon health Common Stock as a grant of restricted stock units. The award was made at no cash cost and is part of her equity-based director compensation with vesting tied to continued board service.

When do Diana McKenzie’s new agilon health (AGL) RSUs vest?

The 2,133 restricted stock units granted to Diana McKenzie vest in full on June 2, 2027. Vesting is conditioned on her continued service as a director through that date, aligning the award with ongoing board tenure and long-term company performance.

How many agilon health (AGL) shares does Diana McKenzie own after this Form 4?

After the reported grant, Diana McKenzie beneficially owns 7,633 shares of agilon health Common Stock. This total includes restricted stock units and reflects the company’s 1-for-25 reverse stock split of its issued and outstanding common stock effective March 30, 2026.

Was cash paid for the agilon health (AGL) shares reported in this Form 4?

No cash was paid for the 2,133 agilon health shares reported; they were granted at a price of $0.00 per share. The transaction represents a compensation-related equity award of restricted stock units rather than an open-market purchase or sale of stock.

How did agilon health’s (AGL) reverse stock split affect this Form 4?

The 7,633 shares Diana McKenzie beneficially owns reflect agilon health’s 1-for-25 reverse stock split effective March 30, 2026. The footnote clarifies that her post-transaction share count is already adjusted to this new share structure, improving comparability to current outstanding shares.